AbbVie Confronts 1st Bellwether In Androgel MDL
AbbVie Inc. is facing its first test in multidistrict litigation accusing the pharmaceutical company and several others of overselling testosterone replacement drugs and not warning of potentially deadly side effects, with...To view the full article, register now.
Already a subscriber? Click here to view full article